Celdaz 500 mg Injection
$12.58
$7.09
Celdaz 500 mg Injection is a potent anticancer treatment indicated for various malignancies, notably advanced malignant melanoma, Hodgkin's lymphoma, and soft tissue sarcomas, which affect the supportive tissues of the body. This injection works by targeting and inhibiting the growth of cancer cells, thereby aiding in the management of these aggressive conditions. It's important to note that Celdaz is not approved for pediatric use due to insufficient data on its safety and effectiveness in children. Patients receiving this treatment may experience side effects, such as anemia, leukopenia, thrombocytopenia, and reduced appetite, which should be monitored closely by healthcare professionals. As with any chemotherapy agent, close supervision and regular blood tests are essential to ensure optimal patient safety and response to therapy. Celdaz plays a critical role in oncology, offering hope to those battling serious cancers while emphasizing the need for informed medical guidance throughout the treatment journey. Always consult your healthcare provider for personalized advice and to discuss potential risks associated with this medication.
Quantity
Active Pharmaceutical Ingredient
Uses
• Celdaz 500 mg injection is utilized in the management of malignant melanoma, which is a severe form of skin cancer originating from melanocytes. This treatment targets the aggressive nature of the disease, aiming to slow its progression. Patients diagnosed with malignant melanoma may receive Celdaz to improve their overall prognosis. The injection is part of a comprehensive treatment plan that often includes other therapies.
• In the context of Hodgkin's disease, Celdaz 500 mg injection serves as an effective treatment option. Hodgkin's disease is a cancer of the lymphatic system, and Celdaz helps combat the disease by targeting the abnormal lymphocytes. Patients typically receive this injection to alleviate symptoms such as swollen lymph nodes and fatigue. It plays a crucial role in the overall management of this type of lymphoma.
• Celdaz 500 mg injection is also indicated for the treatment of soft tissue sarcomas, which are cancers arising from soft tissues such as muscles and connective tissues. This injection works by interfering with cancer cell growth, offering hope to patients facing this challenging diagnosis. The use of Celdaz can be essential in a multi-modal treatment approach, enhancing the effectiveness of other therapies. It provides a targeted option for managing these tumors.
• Additionally, Celdaz 500 mg injection is employed in treating various advanced cancers due to its potent anticancer properties. Its application is often seen in clinical settings where aggressive cancer types are present. By administering Celdaz, healthcare providers aim to improve patient outcomes through effective cancer management strategies. This injection is a vital component in the ongoing battle against various malignancies.
Benefits
Malignant melanoma is a type of skin cancer that develops in the pigment-producing cells of the skin, called melanocytes. It is the most dangerous form of skin cancer and can spread rapidly to other parts of the body if left untreated. Celdaz Injection sticks to the genetic code, called DNA, of the cancer cells and kills them. It also prevents their growth and further spread. This helps to treat cancer. Hodgkin’s disease is a type of lymphoma, which is a blood cancer that starts in the lymphatic system. The lymphatic system helps the immune system get rid of waste and fight infections. Celdaz 500 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Follow your doctor’s instructions carefully. Soft tissue sarcomas: Soft tissue sarcomas are a group of rare cancers that develop in the tissues that support and connect the body, such as muscles, tendons, fat, and blood vessels. They can occur anywhere in the body but are most commonly found in the limbs and trunk. Anticancer Injection Celdaz kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Follow your doctor’s instructions carefully.
Side Effects
Celdaz Injection may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Hair loss
• Nausea
• Vomiting
• Diarrhea
• Sores throat
• Loss of appetite
• Burning or tingling effect on the face
Common Side Effects
• Skin rash
• Fever
• muscle aches
• Difficulty in breathing or swallowing
How To Use
Celdaz 500mg Vial is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of this medicine will depend on the clinical condition of the patient's age and medical history and other factors. It is important to follow your doctor's instructions carefully when using this medication. Do not self-administer.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Celdaz Injection. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Celdaz 500 mg Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Celdaz 500 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Celdaz 500mg Vial. Celdaz Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Celdaz 500 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Celdaz 500 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Celdaz Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Celdaz 500 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Anticancer Injection Celdaz may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Celdaz 500 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Celdaz 500 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Celdaz Injection.